NewsBenzingaFermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160 Fermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160 Benzinga 2026.11.03 17:17 (GMT+0) Open on Benzinga Other news Morgan Stanley Maintains Equal-Weight on Allegion, Raises Price Target to $181 Morgan Stanley Maintains Overweight on Advanced Energy Indus, Lowers Price Target to $368 Oppenheimer Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $94 Truist Securities Reiterates Hold on V2X, Raises Price Target to $87 Anthropic is still grappling with the economics of compute Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305
